This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This EPM2AIP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 39-62 amino acids from the N-terminal region of human EPM2AIP1.
EPM2AIP1
Reaktivität: Human
ELISA
Wirt: Kaninchen
Polyclonal
HRP
Applikationshinweise
WB: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Haltbarkeit
6 months
Ianzano, Zhao, Minassian, Scherer: "Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product." in: Genomics, Vol. 81, Issue 6, pp. 579-87, (2003) (PubMed).
Nagase, Ishikawa, Suyama, Kikuno, Miyajima, Tanaka, Kotani, Nomura, Ohara: "Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." in: DNA research : an international journal for rapid publication of reports on genes and genomes, Vol. 5, Issue 5, pp. 277-86, (1999) (PubMed).
Target
EPM2AIP1
(EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))